Janine Haug

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells

Michael Kline, S. Vincent Rajkumar, Michael Timm et al. · Leukemia · 2007 · 161 citations

Hematological Malignancy, Bcl-2 Family Proteins, Malignant Blood Disorder +8

Expression of VEGF and its receptors by myeloma cells

Shaji Kumar, Thomas E. Witzig, Michael Timm et al. · Leukemia · 2003 · 153 citations

Myeloma Cells, Myelopoiesis, Medicine +5

Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

Alicia Matayoshi, Christopher Brown, John F. DiPersio et al. · Proceedings of the National Academy of Sciences · 1996 · 102 citations · Full text

Stromal Cells, Immunology, Blood Cell +16

Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs

Vijay Ramakrishnan, Michael Timm, Janine Haug et al. · Oncogene · 2009 · 99 citations · Full text

Hematological Malignancy, Common Anti-myeloma Drugs, Significant Anti-myeloma Activity +6

MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma

Vijay Ramakrishnan, Stephen M. Ansell, Janine Haug et al. · Leukemia · 2011 · 73 citations

Hematological Malignancy, Lymphoid Neoplasia, Vitro Pre-clinical Activity +9